SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-125638
Filing Date
2020-11-16
Accepted
2020-11-16 12:35:55
Documents
48
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2029552d1_10q.htm 10-Q 482194
2 EXHIBIT 31.1 tm2029552d1_ex31-1.htm EX-31.1 7934
3 EXHIBIT 31.2 tm2029552d1_ex31-2.htm EX-31.2 7458
4 EXHIBIT 32.1 tm2029552d1_ex32-1.htm EX-32.1 4885
5 EXHIBIT 99.1 tm2029552d1_ex99-1.htm EX-99.1 58372
12 GRAPHIC tm2029552d1_10qimg001.jpg GRAPHIC 18954
13 GRAPHIC logo_001.jpg GRAPHIC 1982
  Complete submission text file 0001104659-20-125638.txt   3774162

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fencf-20200930.xml EX-101.INS 1064998
7 XBRL TAXONOMY EXTENSION SCHEMA fencf-20200930.xsd EX-101.SCH 26622
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fencf-20200930_cal.xml EX-101.CAL 22498
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fencf-20200930_def.xml EX-101.DEF 94141
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE fencf-20200930_lab.xml EX-101.LAB 194967
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fencf-20200930_pre.xml EX-101.PRE 180922
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32295 | Film No.: 201314959
SIC: 2836 Biological Products, (No Diagnostic Substances)